Sales decline 23.08% to Rs 0.10 crore
Rubra Medicaments reported no net profit/loss in the quarter ended December 2020 as against net profit of Rs 0.02 crore during the previous quarter ended December 2019. Sales declined 23.08% to Rs 0.10 crore in the quarter ended December 2020 as against Rs 0.13 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales0.100.13 -23 OPM %015.38 -PBDT00.02 -100 PBT00.02 -100 NP00.02 -100Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
